CiVi Biopharma ApS: Financial statements 2019
CVR: 38027794
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
CiVi Biopharma ApS (CVR 38027794) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 7,236,687 and a net result of DKK 648,729 compared with DKK 706,732 the year before. That is an increase of 19.8% compared with the year before. Equity in the 2019 report amounted to DKK 2,313,059. The solvency ratio was 50.3%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 7,236,687
- Profit/Loss
- DKK 648,729
- Equity
- DKK 2,313,059
- Total Assets
- DKK 4,598,578
- Employees
- 1
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
CiVi Biopharma ApS has published its annual report for 2018. Gross profit came to DKK 6,038,811, and the net result was DKK 706,732.
About CiVi Biopharma ApS
CiVi Biopharma ApS was a Danish company of the type Anpartsselskab based in København Ø, founded in 2016. The company has been dissolved on 5 February 2026. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named CiVi Biopharma A/S. The company has 1 employee (2024). In 2024, the company reported a gross profit of DKK 610,531 and a net result of DKK -1,410,204 compared with DKK -1,887,334 the year before. Equity in the 2024 report amounted to DKK 77,815.